Radboudumc and partners First in man use for hemostatic sealant patch

29 April 2021

Hemostatic sealant solutions innovator GATT Technologies announced today the successful first-in-man of its lead product GATT-Patch, used to resolve bleeding in a patient undergoing liver resection surgery by Radboud university medical center Nijmegen (Radboudumc).

Read the full story here

Related news items

Saving lives with a small pump inside the heart CardiacBooster

31 March 2023 Less damage to organs and a greater chance of survival after having a heart attack. That's what Radboudumc spin-off CardiacBooster is aiming to accomplish. read more

Strategic partnership Enzyre BV and Takeda for better diagnostics for bleeding disorders

31 March 2023 Takeda announced to have entered into a strategic partnership with Enzyre BV, a Radboudumc spin-off company. read more

Aftermovie Investment Day 2022 and a new date for 2023!

31 March 2023

Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.

read more

Radboudumc Investment Day 2022

31 March 2023

Get ready for Radboudumc Investment Day 2022: October 5 in Nijmegen!

read more

Joining forces increases innovation Janssen and Radboud

31 March 2023

Dr. Eng Kinga Matuła (KM), specialist in single-cell multi-omics and Jeroen Van Houdt (JH), Omics group leader at Janssen Pharmaceutica, answer three pressing questions about the successful collaboration in the single-cell technology project.

read more

Acceleration of medical-technological innovations to market by government investment of 8 mln

24 March 2021 This week, the ministries of Economic Affairs and Climate Policy, and Education, Culture and Science awarded 8 million euros to the medtech consortium of the Thematic Technology Transfer (TTT) scheme. read more